PEOPLE - Maxwell Technologies (US) makes appointment:
This article was originally published in Clinica
Maxwell Technologies (San Diego, California), a developer, manufacturer and marketer of electrical components for use in a range of applications including medical imaging, has appointed Richard Balanson as CEO. Mr Balanson, who joined Maxwell in 1999 as corporate vice-president and president of the advanced energy products unit, replaces Carl Eibl, who will continue to serve on the board as well as retaining certain corporate responsibilities.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.